506U78 in Treating Patients With Refractory Hematologic Cancer

NCT00002970 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

NIH

Sponsor class

Conditions

Recurrent Childhood Acute Lymphoblastic Leukemia
Recurrent Childhood Lymphoblastic Lymphoma
T-cell Childhood Acute Lymphoblastic Leukemia

Interventions

DRUG: nelarabine
DRUG: methotrexate
DRUG: cytarabine
DRUG: therapeutic hydrocortisone

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]